Goldman Sachs Group set a CHF 325 target price on Roche (VTX:ROG) in a report issued on Wednesday morning. The brokerage currently has a buy rating on the healthcare company’s stock.

Other research analysts also recently issued research reports about the company. set a CHF 203 target price on Roche and gave the company a sell rating in a report on Friday, October 20th. Baader Bank set a CHF 256 target price on Roche and gave the company a buy rating in a report on Tuesday, November 21st. Berenberg Bank set a CHF 260 target price on Roche and gave the company a neutral rating in a report on Tuesday, October 24th. UBS set a CHF 260 target price on Roche and gave the company a neutral rating in a report on Wednesday, December 6th. Finally, Deutsche Bank set a CHF 254 target price on Roche and gave the company a neutral rating in a report on Thursday, November 23rd. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and eight have issued a buy rating to the company’s stock. The company currently has an average rating of Hold and an average price target of CHF 261.84.

Roche (VTX:ROG) opened at CHF 244.10 on Wednesday. Roche has a 1-year low of CHF 226.10 and a 1-year high of CHF 273.

WARNING: “Goldman Sachs Group Analysts Give Roche (ROG) a CHF 325 Price Target” was published by Watch List News and is owned by of Watch List News. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The original version of this news story can be accessed at https://www.watchlistnews.com/goldman-sachs-group-analysts-give-roche-rog-a-chf-325-price-target-2/1766902.html.

About Roche

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche (VTX:ROG)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.